The Patient Impact of Innovating Gene Editing Methods for Primary Immune Cells

Georgi Makin
21 March 2023
Cell Therapy
Gene Editing
Patient Access & Engagement
Justin McCue, CTO at Avectas, describes the mechanism and benefits of Solupore as well as the impact the technology will have on patient populations.

Justin explains how the rapid but gentle process of Solupore ensures a healthy and highly functioning cell, before comparing the outcomes with other industry processes.

Justin then considers the overall impact these outcomes can have to the patient, including a streamlined process end-to-end,  as well as smaller, highly efficacious dosing.

This interview has been produced in partnership with Avectas and was recorded at Advanced Therapies Week 2023.